19.09.2013 13:49:00
|
Elsevier's ExitCare Receives Meaningful Use Stage 2 Certification
LAKE ELMO, Minnesota, September 19, 2013 /PRNewswire/ --
ExitCare certified as EHR module for patient-specific education resources
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Elsevier's ExitCare has been tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program. This EHR module is compliant in accordance with the criteria adopted by the Secretary of the U.S. Department of Health and Human Services.
Elsevier's ExitCare is an enterprise-wide solution for evidence-based patient education and discharge instructions.
"ExitCare pursued Stage 2 meaningful use certification for the Patient-Specific Education Resources core objective," said Roger Jacobi, Senior Vice President, Patient Education, Elsevier. "Obtaining certification demonstrates ExitCare's commitment to meet the needs of our customers and partners."
Drummond Group's ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology - a key component of the federal government's push to improve clinical care delivery through the adoption and effective use of EHRs by U.S. healthcare providers.
ExitCare's EHR module is 2014 edition compliant, and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human services or guarantee the receipt of incentive payments.
To learn more about ExitCare's recent certification, visit: The Drummond Group's 2014 Edition EHR Products
About Drummond Group Inc.
Drummond Group Inc. is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) - designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Authorized Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, visit http://www.drummondgroup.com or email DGI@drummondgroup.com.
About Elsevier's ExitCare
Elsevier's ExitCare is the most integrated, enterprise-wide provider of print, video and interactive patient education and engagement solutions. With development of thousands of health topics organized by relevant diagnosis and sourced with medication information, the ExitCare product suite provides consistency of information across all care settings and includes 12 different languages and content at various health literacy levels to maximize workflow efficiency, reduce hospital readmissions and increase patient comprehension.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Reed Elsevier plc (Spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |